Celecoxib Capsules(Ⅰ)(Shanghai Shangyao)

塞来昔布胶囊(Ⅰ)（上海上药）

Report date: 2025/08/26 11:21:41

Base Information

Drug NameCelecoxib Capsules(Ⅰ)(Shanghai Shangyao)
Drug Alias NameNiflam塞来考昔Celecoxibum塞来昔布胶囊(Ⅰ)（2.2类改良型）Nu-Celecoxib +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Shangyao Innovative Pharmaceutical Technology Co LTD
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Shangyao Innovative Pharmaceutical Technology Co LTD
Inactive CompaniesN/A
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG